NEW YORK (GenomeWeb News) – Helicos BioSciences has filed a new preliminary prospectus with the US Securities and Exchange Commission for the sale of around 9.6 million shares by shareholders of the firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.